Innovator IBD 50 ETF (FFTY)
ARCA ARCA Primary 
XBER Summary
FFTY Chart
FFTY: Spectacular Returns In 2025 Mask Issues
Innovator IBD® 50 ETF is a passively managed ETF tracking the IBD® 50 Index. FFTY is having such a moment this year, beating IVV and QQQ by a substantial margin. For context, 2017 was the only calendar year when this ETF beat IVV. It is worth exercising caution, though, as it is questionable whether outperformance is sustainable.
Innovator IBD 50 ETF Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| YA Yinka Akinsola Blue Trust Inc. | 515 | $13,827.75 | $19,765.7 | $5,937.95 | 42.94% |
 Bobby Adusumilli SJS Investment Consulting Inc. | 205 | $7,136.05 | $7,867.9 | $731.85 | 10.26% |
| MC mike Chen Byrne Asset Management LLC | 75 | $2,610.75 | $2,926.12 | $315.37 | 12.08% |
 Amanda Hawley Atria Wealth Solutions Inc. | 30,036 | $975,869.64 | $1.18M | $203,343.72 | 20.84% |
 Elliot Kallen Prosperity Wealth Management, Inc. | 8,797 | $328,656.11 | $339,872.09 | $11,215.98 | 3.41% |
Innovator IBD 50 ETF (FFTY) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Innovator IBD 50 ETF ever had a stock split?
Innovator IBD 50 ETF Profile
| ARCA Exchange | US Country |
Overview
The fund described is a financial investment vehicle that primarily focuses on allocating its resources into the securities that are part of the IBD® 50 Index. This index is distinctive due to its origins; it is a product of Investor's Business Daily® (IBD), a reputable publication known for its comprehensive market analysis and investment insights. The IBD® 50 Index, in particular, is formulated through a rigorous, rules-based, algorithm-driven process designed to pinpoint the top 50 growth stocks at any given time. Through its commitment to invest at least 80% of its net assets, including funds obtained through investment borrowings, into the securities making up this index, the fund aims to mirror the performance of some of the most dynamic companies identified by IBD's specialized criteria.
Products and Services
- IBD® 50 Index Investment
- Investment Borrowing Strategy
The cornerstone of the fund's investment strategy is the acquisition of securities that form the IBD® 50 Index. This product involves a dynamic approach to equity investment, emphasizing stocks that exhibit strong growth characteristics. By channeling a major portion of its assets into these securities, the fund aims to offer investors exposure to top-performing growth stocks, as identified by IBD's proprietary analysis methods.
As part of its investment methodology, the fund employs a strategy that includes the use of borrowed funds to increase the volume of its investments in the IBD® 50 Index securities. This leveraged approach is designed to amplify the investment's exposure to the index's performance, potentially enhancing the returns for investors but also increasing the risk profile of the investment.
